These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 5049808)

  • 1. Response of patients with postencephalitic Parkinsonism to levodopa.
    Duvoisin RC; Lobo-Antunes J; Yahr MD
    J Neurol Neurosurg Psychiatry; 1972 Aug; 35(4):487-95. PubMed ID: 5049808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levodopa in postencephalitic parkinsonism.
    Hunter KR; Stern GM; Sharkey J
    Lancet; 1970 Dec; 2(7687):1366-7. PubMed ID: 4098944
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of parkinsonism with levodopa.
    Yahr MD; Duvoisin RC; Schear MJ; Barrett RE; Hoehn MM
    Arch Neurol; 1969 Oct; 21(4):343-54. PubMed ID: 5820999
    [No Abstract]   [Full Text] [Related]  

  • 4. L-dopa in postencephalitic parkinsonism.
    Calne DB; Stern GM; Laurence DR; Sharkey J; Armitage P
    Lancet; 1969 Apr; 1(7598):744-6. PubMed ID: 4180215
    [No Abstract]   [Full Text] [Related]  

  • 5. A year's experience of L-DOPA in the treatment of Parkinson's disease.
    Guidetti B; Giuffrè R
    Acta Neurochir (Wien); 1971; 24(2):81-8. PubMed ID: 5112463
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
    Parkes JD; Baxter RC; Marsden CD; Rees JE
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):422-6. PubMed ID: 4838913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-dopa in idiopathic parkinsonism.
    Calne DB; Stern GM; Spiers AS; Laurence DR
    Lancet; 1969 Nov; 2(7628):973-6. PubMed ID: 4186975
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of parkinsonism with the drug L-DOPA].
    Stoliarova LG; Kistenev BA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170
    [No Abstract]   [Full Text] [Related]  

  • 10. L-dopa in the treatment of parkinsonism.
    Haleem MA
    Gerontol Clin (Basel); 1972; 14(4):242-8. PubMed ID: 4634915
    [No Abstract]   [Full Text] [Related]  

  • 11. L-dopa for postencephalitic Parkinsonism.
    Krasner N; Cornelius JM
    Br Med J; 1970 Nov; 4(5733):496. PubMed ID: 5481239
    [No Abstract]   [Full Text] [Related]  

  • 12. A historical analysis of the relationship between encephalitis lethargica and postencephalitic parkinsonism: a complex rather than a direct relationship.
    Vilensky JA; Gilman S; McCall S
    Mov Disord; 2010 Jul; 25(9):1116-23. PubMed ID: 20629120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E; D'Andrea F; Signorelli CD
    Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Parkinson's disease with L-dopa: a current appraisal.
    Kofman O
    Can Med Assoc J; 1971 Mar; 104(6):483-7. PubMed ID: 5549988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentration of levodopa in patients with Parkinson's disease.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1973; 10(5):301-10. PubMed ID: 4789106
    [No Abstract]   [Full Text] [Related]  

  • 16. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F; Baroni A; Roveyaz L
    Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term treatment of Parkinsonism with L-dopa.
    Presthus J; Holmsen R
    Acta Neurol Scand Suppl; 1972; 51():131-2. PubMed ID: 4514340
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of age and arteriosclerosis on the response of Parkinsonian patients to levodopa.
    Godwin-Austen RB; Bergmann S; Frears CC
    Br Med J; 1971 Nov; 4(5786):522-4. PubMed ID: 4942463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DOPA in Parkinson's disease.
    Lancet; 1969 Apr; 1(7600):871-2. PubMed ID: 4180531
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychosis and other psychiatric manifestations of levodopa therapy.
    Celesia GG; Barr AN
    Arch Neurol; 1970 Sep; 23(3):193-200. PubMed ID: 5456717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.